EUVIMEDEUVIMED entdecken
Crossref

Killer cell lectin-like receptor G2 facilitates aggressive phenotypes of gastric cancer cells via dual activation of the ERK1/2 and JAK/STAT pathways

Yuki Ito, Mitsuro Kanda iD, Masahiro Sasahara, Chie Tanaka, Dai Shimizu, Shinichi Umeda, Yoshikuni Inokawa, Norifumi Hattori, Masamichi Hayashi, Goro Nakayama, Yasuhiro Kodera

Gastric Cancer · 2024

DOI: 10.1007/s10120-024-01480-y ↗

Kurz gefasst

Fachartikel in der Zeitschrift Gastric Cancer, 2024. Verfasst von Yuki Ito und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterological Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-Cho, Showa-Ku, Nagoya, 466-8550, Japan. Hauptthemen laut MEDLINE: Janus Kinases, Stomach Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Advanced gastric cancer (GC) has a poor prognosis. This study aimed to identify novel GC-related genes as potential therapeutic targets. METHODS: Killer cell lectin-like receptor G2 (KLRG2) was identified as a candidate gene by transcriptome analysis of metastatic GC tissues. Small interfering RNA-mediated KLRG2 knockdown in human GC cell lines was used to investigate KLRG2 involvement in signaling pathways and functional behaviors in vitro and in vivo. Clinicopathological data were analyzed in patients stratified according to tumor KLRG2 mRNA expression. RESULTS: KLRG2 knockdown in GC cells decreased cell proliferation, migration, and invasion; caused cell cycle arrest in G2/M phase; induced apoptosis via caspase activation; suppressed JAK/STAT and MAPK-ERK1/2 pathway activities; and upregulated p53 and p38 MAPK activities. In mouse xenograft models of peritoneal metastasis, the number and weight of disseminated GC nodules were decreased by KLRG2 knockdown. High tumor levels of KLRG2 mRNA were significantly associated with lower 5-year overall survival (OS) and relapse-free survival (RFS) rates in patients with Stage I-III GC (5-year OS rate: 64.4% vs. 80.0%, P = 0.009; 5-year RFS rate: 62.8% vs. 78.1%, P = 0.030). CONCLUSIONS: KLRG2 knockdown attenuated the malignant phenotypes of GC cells via downregulation of JAK/STAT and MAPK-ERK1/2 pathway activity and upregulation of p38 MAPK and p53. Targeted suppression of KLRG2 may serve as a new treatment approach for GC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Janus KinasesStomach NeoplasmsHumansAnimalsMiceSignal TransductionMAP Kinase Signaling SystemTumor Suppressor Protein p53STAT Transcription FactorsCell Proliferationp38 Mitogen-Activated Protein KinasesRNA, MessengerReceptors, NK Cell Lectin-LikeCell Line, TumorGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

Extracellular signal-regulated kinase 1/2Gastric cancerJanus kinase-signal transducer and transcription activatorKiller cell lectin-like receptor G2Xenograft model

Substanzen

Janus KinasesTumor Suppressor Protein p53STAT Transcription Factorsp38 Mitogen-Activated Protein KinasesRNA, MessengerReceptors, NK Cell Lectin-Like

Autor:innen und Institutionen

  • Department of Gastroenterological Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-Cho, Showa-Ku, Nagoya, 466-8550, Japan.
  • Department of Gastroenterological Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-Cho, Showa-Ku, Nagoya, 466-8550, Japan. m-kanda@med.nagoya-u.ac.jp.

ORCID-Profile: Mitsuro Kanda

Zitieren

APA

Ito, Y., Kanda, M., Sasahara, M., Tanaka, C., Shimizu, D., Umeda, S., Inokawa, Y., Hattori, N., Hayashi, M., Nakayama, G., & Kodera, Y. (2024). Killer cell lectin-like receptor G2 facilitates aggressive phenotypes of gastric cancer cells via dual activation of the ERK1/2 and JAK/STAT pathways. Gastric Cancer. https://doi.org/10.1007/s10120-024-01480-y

Vancouver

Ito Y, Kanda M, Sasahara M, Tanaka C, Shimizu D, Umeda S, et al. Killer cell lectin-like receptor G2 facilitates aggressive phenotypes of gastric cancer cells via dual activation of the ERK1/2 and JAK/STAT pathways. Gastric Cancer. 2024. doi:10.1007/s10120-024-01480-y

BibTeX
@article{Ito2024,
  author = {Ito, Yuki and Kanda, Mitsuro and Sasahara, Masahiro and Tanaka, Chie and Shimizu, Dai and Umeda, Shinichi and Inokawa, Yoshikuni and Hattori, Norifumi and Hayashi, Masamichi and Nakayama, Goro and Kodera, Yasuhiro},
  title = {Killer cell lectin-like receptor G2 facilitates aggressive phenotypes of gastric cancer cells via dual activation of the ERK1/2 and JAK/STAT pathways},
  journal = {Gastric Cancer},
  year = {2024},
  doi = {10.1007/s10120-024-01480-y}
}
Kostenlos starten →